GLT’s primary function is to carry out innovative, industry–led research and development to provide green and sustainable solutions to industrial problems.
Read moreRe–Vana Therapeutics is an ocular pharmaceuticals and drug delivery company focused on the development and commercialisation of innovative long–acting biodegradable drug delivery platforms to treat chronic eye diseases.
Read moreCirdan is a leading provider of informatics and imaging solutions that enhance and speed up the diagnosis of patients.
Read moreProlific. Diverse. Sustainable. At QUBIS we have an impressive track record when it comes to helping start-ups to succeed.
Prolific – We’ve helped to create 100+ spin-outs since 1984, and remain a shareholder in more than 40.
Diverse – Our portfolio reflects the research base of Queen’s, including companies covering software, physics, engineering, pharmacy and life sciences.
Sustainable – We’ve guided companies down many routes to success, from organic growth, to venture capital funding and angel investment.
We look forward to adding your success story to our portfolio.